Log in

Start free trial
Home 5 Lab Industry Advisor 5 Essential 5 FDA Will Not Appeal Ruling Against LDT Regulation, Giving a Big Victory to Labs

FDA Will Not Appeal Ruling Against LDT Regulation, Giving a Big Victory to Labs

by | Jul 11, 2025 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor, Labs in Court-nir, LDTs-lir

The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight

LDT regulation has stalled out thanks to FDA's decision not appeal a court decision.
iStock, beast01

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE